BCPC (Balchem Corporation)
Insider Trading Activity
Every open-market purchase and sale reported by BCPC officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-13 | David B Fischer | Director | A | — | — |
| 2026-02-13 | Kathleen B Fish | Director | A | — | — |
| 2026-02-13 | Daniel E Knutson | Director | A | — | — |
| 2026-02-13 | Olivier Rigaud | Director | A | — | — |
| 2026-02-13 | MONICA VICENTE | Director | A | — | — |
| 2026-02-13 | George Graham | SVP and Chief R&D Officer | A | — | — |
| 2026-02-13 | Frederic Boned | SVP/GM, Human Nutri. & Health | MIXED | — | — |
| 2026-02-13 | Martin Luther Reid | SVP Chief Supply Chain Officer | MIXED | — | — |
| 2026-02-13 | Michael Brent Tignor | SVP & Chief HR Officer | MIXED | — | — |
| 2026-02-13 | Matthew David Wineinger | Director | A | — | — |
| 2026-02-13 | Carl Martin Bengtsson | EVP & Chief Financial Officer | MIXED | — | — |
| 2026-02-13 | William A. Backus | VP & Chief Accounting Officer | MIXED | — | — |
| 2026-02-13 | Hatsuki Miyata | EVP, CLO, & Secretary | MIXED | — | — |
| 2026-02-13 | Theodore L Harris | Chairman, President & CEO | MIXED | — | — |
| 2026-02-13 | Job Leonard van Gunsteren | SVP and GM, Specialty Products | MIXED | — | — |
| 2026-02-10 | William A. Backus | VP & Chief Accounting Officer | F | — | — |
| 2026-02-10 | Job Leonard van Gunsteren | SVP and GM, Specialty Products | F | — | — |
| 2026-02-10 | Hatsuki Miyata | EVP, CLO, & Secretary | F | — | — |
| 2026-02-10 | Theodore L Harris | Chairman, President & CEO | F | — | — |
| 2026-02-10 | Martin Luther Reid | SVP Chief Supply Chain Officer | F | — | — |
| 2026-02-10 | William A. Backus | VP & Chief Accounting Officer | F | — | — |
| 2026-02-10 | Frederic Boned | SVP/GM, Human Nutri. & Health | F | — | — |
| 2026-02-10 | Michael Brent Tignor | SVP & Chief HR Officer | F | — | — |
| 2026-02-10 | Carl Martin Bengtsson | EVP & Chief Financial Officer | F | — | — |
| 2025-12-05 | David B Fischer | Director | MIXED | — | — |
| 2025-12-05 | Job Leonard van Gunsteren | SVP and GM, Specialty Products | MIXED | — | — |
| 2025-11-13 | Martin Luther Reid | SVP Chief Supply Chain Officer | Sell | — | — |
| 2025-11-03 | Frederic Boned | SVP/GM, Human Nutri. & Health | F | — | — |
| 2025-10-22 | George Graham | SVP and Chief R&D Officer | A | — | — |
| 2025-07-28 | Hatsuki Miyata | EVP, CLO, & Secretary | F | — | — |
| 2025-04-11 | David B Fischer | Director | A | — | — |
| 2025-04-11 | Daniel E Knutson | Director | A | — | — |
| 2025-04-11 | Job Leonard van Gunsteren | SVP and GM, Specialty Products | MIXED | — | — |
| 2025-04-11 | Hatsuki Miyata | EVP, CLO, & Secretary | A | — | — |
| 2025-04-11 | Frederic Boned | SVP/GM, Human Nutri. & Health | A | — | — |
| 2025-04-11 | MONICA VICENTE | Director | A | — | — |
| 2025-04-11 | Theodore L Harris | Chairman, President & CEO | MIXED | — | — |
| 2025-04-11 | Matthew David Wineinger | Director | A | — | — |
| 2025-04-11 | Olivier Rigaud | Director | A | — | — |
| 2025-04-11 | Martin Luther Reid | SVP Chief Supply Chain Officer | MIXED | — | — |
| 2025-04-11 | Carl Martin Bengtsson | EVP & Chief Financial Officer | MIXED | — | — |
| 2025-04-11 | Kathleen B Fish | Director | A | — | — |
| 2025-04-11 | William A. Backus | VP & Chief Accounting Officer | MIXED | — | — |
| 2025-04-11 | Michael Brent Tignor | SVP & Chief HR Officer | MIXED | — | — |
| 2025-02-14 | Matthew David Wineinger | Director | A | — | — |
| 2025-02-14 | Daniel E Knutson | Director | A | — | — |
| 2025-02-14 | David B Fischer | Director | A | — | — |
| 2025-02-14 | Kathleen B Fish | Director | A | — | — |
| 2025-02-14 | MONICA VICENTE | Director | A | — | — |
| 2025-02-14 | William A. Backus | VP & Chief Accounting Officer | MIXED | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Chairman, President & CEO | 92,395 | — |
| — | Vice President | 68,726 | — |
| — | Director | 56,068 | — |
| — | Director | 51,366 | — |
| — | Director | 51,008 | — |
| — | VP Human Resources | 50,926 | — |
| — | V P & General Manger | 46,561 | — |
| — | VP, R&D | 42,588 | — |
| — | Vice President | 36,685 | — |
| — | Director | 29,697 | — |
| — | EVP & Chief Financial Officer | 29,314 | — |
| — | Director | 29,078 | — |
| — | Director | 24,495 | — |
| — | Director | 22,540 | — |
| — | Chief Operating Officer | 21,218 | — |
| — | General Counsel/Secretary | 20,050 | — |
| — | Sr. Vice President | 15,915 | — |
| — | SVP & GM, Animal Nutrition | 12,737 | — |
| — | SVP & Chief HR Officer | 12,344 | — |
| — | SVP and GM, Specialty Products | 10,963 | — |
| — | Vice President | 9,675 | — |
| — | Director | 8,859 | — |
| — | SVP/GM, Human Nutri. & Health | 8,526 | — |
| — | SVP Chief Supply Chain Officer | 8,457 | — |
| — | EVP, CLO, & Secretary | 8,043 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the BCPC quote page; the site-wide leaderboard is on the insider transactions hub.